Neon Therapeutics Presents Updated Data At The Society For Immunotherapy Of Cancers 33rd Annual Meeting | Latest News RSS feed

Neon Therapeutics Presents Updated Data At The Society For Immunotherapy Of Cancers 33rd Annual Meeting - Latest News


Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

CAMBRIDGE, Mass., Nov 09, 2018 (GLOBE NEWSWIRE via COMTEX) -- - Management Hosting Webcast of Key Opinion Leader Discussion Today at 6:00 p.m. ET - Neon Therapeutics, Inc. NTGN, -1.85% a ... read more

Neon Therapeutics to Present at the Society for Immunotherapy of Cancer 33rd Annual Meeting

Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced upcoming presentations at the Society for Immunotherapy of ... read more

Neon Therapeutics Is An Emerging Player In Personalized Immunotherapy With Catalysts Ahead

In the case of Neon, we have a data update for its NT-001 ... Neon will present potentially a broader set of results on NEO-PV-01 at the Society of Immunotherapy of Cancer (SITC) Annual Meeting taking ... read more

Looking for another news?


Neon Therapeutics Provides Business Update and Outlook for 2019

Jan. 03, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics ... Neon continues to build on data presented at the Society for the Immunotherapy of Cancer 2018 Annual Meeting. The Company plans to file a ... read more


Neon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

“We have also made important developments in our NEO-PTC-01 program, including the evaluation of additional patient sample materials, which builds upon data presented at the Society for Immunotherapy ... read more

Neon Therapeutics to Host Investor Event at Society for Immunotherapy of Cancer 33rd Annual Meeting

Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it will host an investor event at the Society for ... read more

Neon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Neon Therapeutics, Inc. (NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today reported financial results for the fourth quarter and full-year ended December ... read more

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated ... read more

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

- Management Hosting Webcast of Key Opinion Leader Discussion Today at 6:00 p.m. ET - CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. NTGN, -3.32% a clinical-stage ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us